Royale Announces Collaboration with QVance
Royale International is excited to announce its collaboration with QVance Sweden AB. Both companies aim to deliver tailored temperature-controlled logistics solutions for the clinical trial process cycle.
QVance is a quality analytics service provider for advanced therapies. In brief, the company’s vision is to be a one-stop analytics service supporting customers throughout development and drug product lifecycle. Thus, this collaboration will leverage QVance’s quality standards and enhance Royale’s global Quality Management System (QMS) for better personalised bio-logistics offerings. Together, the companies will support global advancements in biotechnology and pharmaceuticals, from research & development (R&D) to commercial of the process.
Royale International –
“Royale International is delighted with our newly formed strategic partnership with QVance. Both companies share a culture of dynamism and flexibility that is very much required in the advanced therapy landscape at present,” says Philip Murton, Global Sales Director of Life Sciences at Royale International. “The core values of our company are centric on the customer and providing tailored solutions to their needs through shared experience, innovation and collaboration. “Quality forms an integral part of these solutions and bringing Royale International together with QVance demonstrates our recognition of this,” says Soren Knudsen, Regional Head, Life Sciences. Addtionally, the collaboration aims to expand Royale’s bio-logistics services as well as provide education with joint events to various biopharma companies globally. Both companies commit to uphold excellence and innovation while achieving mutual goals and support the advancement of life sciences.
QVance –
“Partnering with Royale International and addresses the need for cold chain solutions throughout the manufacturing and release of cell and gene therapy products,” says Lindsay Davies, CSO of QVance’s parent company NextCell Pharma AB and co-founder of QVance. “Royale International’s personal approach to handling of drug products during storage and transport, and their recognition of the need to offer bespoke solutions, complements our ethos at QVance, to put the customer and their products quality first. Overall, we recognise that with advanced therapies there is a need to be innovative in establishing solutions for quality control and standardised handling, and that a one size fits all approach is not suitable for our customers.”
Find Official Statement here.
Learn more about our Life Sciences services.
|  |
